サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1750634

多嚢胞性卵巣症候群治療の世界市場規模、シェア、動向分析レポート：薬剤クラス別、手術別、流通チャネル別、地域別、セグメント別予測（2025年～2030年）

Polycystic Ovarian Syndrome Treatment Market Size, Share & Trends Analysis Report By Drug Class, By Surgery, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
多嚢胞性卵巣症候群治療の世界市場規模、シェア、動向分析レポート：薬剤クラス別、手術別、流通チャネル別、地域別、セグメント別予測（2025年～2030年）
出版日: 2025年05月22日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

多嚢胞性卵巣症候群治療市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の多嚢胞性卵巣症候群治療の市場規模は2030年までに69億9,000万米ドルに達し、2025年～2030年のCAGRは6.6％を記録すると推定されています。米国疾病管理予防センター（CDC）によると、多嚢胞性卵巣症候群（PCOS）は女性不妊の最も一般的な原因です。米国では、生殖年齢にある女性の約6％～12％がPCOSに罹患しています。さらに、この病態が進行すると代謝異常が起こり、治療が遅れると2型糖尿病を発症する可能性があります。この疾患の重症度は、患者の子宮体がんや子宮内膜がんの発症リスクを高めます。したがって、早期診断と効果的な治療が回復のために重要です。

現在のところ、この疾患に対する特効薬は市販されていません。したがって、症状を治療することが治療法の第一の目的です。この症候群に伴う様々な症状のため、治療には様々な薬剤クラス/組み合わせが使用されます。そのため、市場のリーダーたちは、この疾患の根本原因を治療するための特定の薬剤/治療法の開発に注力しています。アストラゼネカは、そのような薬剤の開発に携わっているリーダーの1社です。

多嚢胞性卵巣症候群治療市場レポートのハイライト

  • 薬剤クラス別では、インスリン抵抗性改善薬が市場を独占し、2024年には36.0％のシェアを占めました。
  • 手術別では、卵巣楔状切除術が予測期間中に大幅なCAGRで成長する見込みです。
  • 販売チャネル別では、オンラインプロバイダーセグメントが予測期間中に最も速いCAGRを記録する見込みです。
  • アジア太平洋の多嚢胞性卵巣症候群治療市場は予測期間中に最も速いCAGRを記録すると予測されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 多嚢胞性卵巣症候群治療市場の変数、動向、範囲

  • 市場イントロダクション/系統展望
  • 市場規模と成長見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 多嚢胞性卵巣症候群治療市場の分析ツール
    • ポーターの分析
    • PESTEL分析

第4章 多嚢胞性卵巣症候群治療市場：薬剤クラスの推定・動向分析

  • セグメントダッシュボード
  • 多嚢胞性卵巣症候群治療市場：薬剤クラスの変動分析、2024年および2030年
  • 経口避妊薬
  • 抗アンドロゲン
  • インスリン抵抗性改善薬
  • 抗うつ薬
  • 肥満予防

第5章 多嚢胞性卵巣症候群治療市場：手術の推定・動向分析

  • セグメントダッシュボード
  • 多嚢胞性卵巣症候群治療市場：手術の変動分析、2024年および2030年
  • 卵巣楔状切除術
  • 腹腔鏡下卵巣穿孔術

第6章 多嚢胞性卵巣症候群治療市場：流通チャネルの推定・動向分析

  • セグメントダッシュボード
  • 多嚢胞性卵巣症候群治療市場：流通チャネルの変動分析、2024年および2030年
  • 院内薬局
  • ドラッグストアと小売薬局
  • オンラインプロバイダー

第7章 多嚢胞性卵巣症候群治療市場：地域の推定・動向分析

  • 多嚢胞性卵巣症候群治療市場シェア：地域別、2024年および2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
  • ラテンアメリカ
    • ブラジル
  • 中東およびアフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業分類
  • 企業ヒートマップ分析
  • 企業プロファイル
    • AstraZeneca
    • Bayer AG
    • Merck KGaA.
    • Abbott
    • Pfizer, Inc
    • Sanofi
    • Bristol Myers Squibb Company
    • Teva Pharmaceutical Industries Ltd
    • Novartis AG
    • Ferring BV
図表

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Leading Market Players Anticipated to Witness Highest Growth
  • Table 4. Global polycystic ovarian syndrome treatment market, By Region, 2018 - 2030 (USD Billion)
  • Table 5. Global polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 6. Global polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 7. Global polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 8. North America polycystic ovarian syndrome treatment market, By Country, 2018 - 2030 (USD Billion)
  • Table 9. North America polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 10. North America polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 11. North America polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 12. U.S. polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 13. U.S. polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 14. U.S. polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 15. Canada polycystic ovarian syndrome treatment market, By, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 16. Canada polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 17. Canada polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 18. Mexico polycystic ovarian syndrome treatment market, By, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 19. Mexico polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 20. Mexico polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 21. Europe polycystic ovarian syndrome treatment market, By Country, 2018 - 2030 (USD Billion)
  • Table 22. Europe polycystic ovarian syndrome treatment market, By, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 23. Europe polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 24. Europe polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 25. UK polycystic ovarian syndrome treatment market, By, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 26. UK polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 27. UK polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 28. Germany polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 29. Germany polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 30. Germany polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 31. France polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 32. France polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 33. France polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 34. Italy polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 35. Italy polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 36. Italy polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 37. Spain polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 38. Spain polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 39. Spain polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 40. Denmark polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 41. Denmark polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 42. Denmark polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 43. Sweden polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 44. Sweden polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 45. Sweden polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 46. Norway polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 47. Norway polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 48. Norway polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 49. Asia Pacific polycystic ovarian syndrome treatment market, By Country, 2018 - 2030 (USD Billion)
  • Table 50. Asia Pacific polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 51. Asia Pacific polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 52. Asia Pacific polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 53. Japan polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 54. Japan polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 55. Japan polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 56. China polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 57. China polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 58. China polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 59. India polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 60. India polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 61. India polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 62. South Korea polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 63. South Korea polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 64. South Korea polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 65. Australia polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 66. Australia polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 67. Australia polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 68. Thailand polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 69. Thailand polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 70. Thailand polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 71. Latin America polycystic ovarian syndrome treatment market, By Country, 2018 - 2030 (USD Billion)
  • Table 72. Latin America polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 73. Latin America polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 74. Latin America polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 75. Brazil polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 76. Brazil polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 77. Brazil polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 78. Argentina polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 79. Argentina polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 80. Argentina polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 81. Middle East and Africa polycystic ovarian syndrome treatment market, By Country, 2018 - 2030 (USD Billion)
  • Table 82. Middle East and Africa polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 83. Middle East and Africa polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 84. Middle East & Africa polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 85. South Africa polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 86. South Africa polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 87. South Africa polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 88. Saudi Arabia polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 89. Saudi Arabia polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 90. Saudi Arabia polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 91. UAE polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 92. UAE polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 93. UAE polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 94. Kuwait polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 95. Kuwait polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 96. Kuwait polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Polycystic ovarian syndrome treatment market segment scope and defination
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2024)
  • Fig. 10 Strategy framework
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 Polycystic ovarian syndrome treatment market:, By Drug Class movement analysis
  • Fig. 17 Polycystic ovarian syndrome treatment market:, By Drug Class segment dashboard
  • Fig. 18 Polycystic ovarian syndrome treatment market, By Drug Class outlook: Key takeaways
  • Fig. 19 Luminometric Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 20 Enzymatic Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 21 Bioluminescence Resonance Energy Transfer (BRET) Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 22 Cell-based Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 23 Anti-obesity Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 24 Polycystic ovarian syndrome treatment market: Surgery movement analysis
  • Fig. 25 Polycystic ovarian syndrome treatment market Surgery outlook: Key takeaways
  • Fig. 26 Ovarian Wedge Resection Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 27 Laparoscopic Ovarian Drilling Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 28 Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 29 Food Safety and Quality TestingPolycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 30 Other Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 31 Polycystic ovarian syndrome treatment market: Distribution Channel movement analysis
  • Fig. 32 Polycystic ovarian syndrome treatment market Distribution Channel outlook: Key takeaways
  • Fig. 33 Hospital Pharmacy Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 34 Drug Store & Retail Pharmacy Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 35 Online Providers Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 36 Regional outlook, 2024 & 2030
  • Fig. 37 Regional market dashboard
  • Fig. 38 Regional market place: Key takeaways
  • Fig. 39 North America polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 40 U.S. polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 41 Canada polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 42 Mexico polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 43 Europe polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 44 UK polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 45 Germany polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 46 Spain polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 47 France polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 48 Italy implantable Market, 2018 - 2030 (USD Billion)
  • Fig. 49 Denmark polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 50 Sweden polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 51 Norway polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 52 Asia Pacific polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 53 Japan polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 54 China polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 55 India polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 56 South Korea polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 57 Australia polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 58 Thailand polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 59 Latin America polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 60 Brazil polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 61 Argentina polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 62 MEA polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 63 South Africa polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 64 Saudi Arabia polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 65 UAE polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 66 Kuwait polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 67 Heat map analysis
  • Fig. 68 Market differentiators
目次
Product Code: GVR-2-68038-203-7

Polycystic Ovarian Syndrome Treatment Market Growth & Trends:

The global polycystic ovarian syndrome treatment market size is estimated to reach USD 6.99 billion by 2030, registering a CAGR of 6.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. According to the Centers of Disease Control & Prevention (CDC), Polycystic Ovary Syndrome (PCOS) is the most common cause of female infertility. Approximately 6% to 12% women of reproductive age suffer from PCOS in the U. S. Moreover, progression of this condition can lead to metabolic abnormalities, which may result in development of type 2 diabetes, if the syndrome is not treated on time. The severity of the disorder increases the risk of developing uterine and endometrial cancers in patients. Thus, early diagnosis and effective treatment are significant for successful recovery.

Presently, no specific drug is commercially available for this condition. Thus, treating symptoms is the prime aim of the treatment regimen. Owing to the various symptoms associated with this syndrome, a range of drug class/combinations is used in the treatment. Therefore, market leaders are focusing on developing a specific drug/treatment to cure the root cause of this disease. AstraZeneca is one of the leaders involved in developing such a drug.

Polycystic Ovarian Syndrome Treatment Market Report Highlights:

  • Based on drug class, the insulin-sensitizing agents dominated the market and accounted for a share of 36.0% in 2024.
  • By surgery, the ovarian wedge resection segment is expected to grow at a significant CAGR over the forecast period.
  • Based on the distribution channel, the online providers segment is expected to register the fastest CAGR during the forecast period.
  • Asia Pacific's polycystic ovarian syndrome treatment market is estimated to register the fastest CAGR over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Polycystic Ovarian Syndrome Treatment Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Billion)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Polycystic Ovarian Syndrome Treatment Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Polycystic Ovarian Syndrome Treatment Market: Drug Class Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Polycystic Ovarian Syndrome Treatment Market:, Drug Class Movement Analysis, 2024 & 2030 (USD Billion)
  • 4.3. Oral Contraceptives
    • 4.3.1. Oral Contraceptives Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.4. Antiandrogens
    • 4.4.1. Antiandrogens Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.5. Insulin-sensitizing Agent
    • 4.5.1. Insulin-sensitizing Agent Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.6. Antidepressant
    • 4.6.1. Antidepressant Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.7. Anti-obesity
    • 4.7.1. Anti-obesity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Polycystic Ovarian Syndrome Treatment Market: Surgery Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Polycystic Ovarian Syndrome Treatment Market: Surgery Movement Analysis, 2024 & 2030 (USD Billion)
  • 5.3. Ovarian Wedge Resection
    • 5.3.1. Ovarian Wedge Resection Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.4. Laparoscopic Ovarian Drilling
    • 5.4.1. Laparoscopic Ovarian Drilling Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Polycystic Ovarian Syndrome Treatment Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Polycystic Ovarian Syndrome Treatment Market: Distribution Channel Movement Analysis, 2024 & 2030 (USD Billion)
  • 6.3. Hospital Pharmacy
    • 6.3.1. Hospital Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.4. Drug Store & Retail Pharmacy
    • 6.4.1. Drug Store & Retail Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Online Providers
    • 6.5.1. Online Providers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Polycystic Ovarian Syndrome Treatment Market: Regional Estimates & Trend Analysis

  • 7.1. Polycystic Ovarian Syndrome Treatment Market Share, By Region, 2024 & 2030 (USD Billion)
  • 7.2. North America
    • 7.2.1. North America Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.2. U.S.
    • 7.2.3. U.S. Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.4. Canada
      • 7.2.4.1. Canada Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.5. Mexico
      • 7.2.5.1. Mexico Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.3. Europe
    • 7.3.1. Europe Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.2. UK
      • 7.3.2.1. UK Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.4. France
      • 7.3.4.1. France Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.2. China
      • 7.4.2.1. China Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.4. India
      • 7.4.4.1. India Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5. Latin America
    • 7.5.1. Latin America Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.2. Saudi Arabia
      • 7.6.2.1. Saudi Arabia Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.3. UAE
      • 7.6.3.1. UAE Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.4. South Africa
      • 7.6.4.1. South Africa Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. AstraZeneca
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. Bayer AG
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Merck KGaA.
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Abbott
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Pfizer, Inc
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Sanofi
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. Bristol Myers Squibb Company
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Teva Pharmaceutical Industries Ltd
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Novartis AG
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Ferring B.V.
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives